  Anti-ischemia activity of HU-211, a non-psychotropic synthetic cannabinoid.  Vered M(1), Bar-Joseph A, Belayev L, Berkovich Y, Biegon A.  Author information:  (1)Pharmos Ltd., Kiryat Weizmann, Rehovot, Israel.  The novel tricyclic-terpenoid type cannabinoid, HU-211, was tested in gerbils and rats for protection against the effects of cerebral ischemia. Our transient